The Impact of Hangeshashinto on Symptoms and Gut Microbiota in Diarrhea-type Irritable Bowel Syndrome: A Retrospective Analysis

The Impact of Hangeshashinto on Symptoms and Gut Microbiota in Diarrhea-type Irritable Bowel Syndrome: A Retrospective Analysis

Objectives: Effective treatments for diarrhea-type irritable bowel syndrome (IBS-D) are limited. Hangeshashinto (HST), an anti-inflammatory Kampo medicine, may offer benefits but its efficacy for IBS-D requires further investigation. This study evaluated IBS-D symptom improvement and gut microbiota...

Full description

Saved in:
Bibliographic Details
Main Authors: Naohisa Yoshida, Takeshi Yasuda, Yoshikazu Inagaki, Daisuke Hasegawa, Kohei Fukumoto, Takaaki Murakami, Ryohei Hirose, Osamu Dohi, Kazuhiko Uchiyama, Tomohisa Takagi, Yoshito Itoh
Format: Article
Language:English
Published: The Japan Society of Coloproctology 2025-01-01
Series:Journal of the Anus, Rectum and Colon
Subjects:
irritable bowel syndrome
diarrhea
microbiota
kampo medicine
Online Access:https://www.jstage.jst.go.jp/article/jarc/9/1/9_2024-068/_pdf/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items